{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:14:45Z","timestamp":1767183285099,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jogoh.2024.102850","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:36:21Z","timestamp":1726612581000},"page":"102850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of intravenous calcium gluconate on the prevention of ovarian hyperstimulation syndrome. (A randomized clinical trial)"],"prefix":"10.1016","volume":"53","author":[{"given":"Marzieh","family":"Lotfalizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayereh","family":"Khadem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4396-2707","authenticated-orcid":false,"given":"Tahere","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1439-8828","authenticated-orcid":false,"given":"Nafiseh","family":"Jahanpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7732-2142","authenticated-orcid":false,"given":"Mahbobeh","family":"Mahmoudinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-1499","authenticated-orcid":false,"given":"Pardis","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-393X","authenticated-orcid":false,"given":"Faezeh","family":"Zakerinasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-3313","authenticated-orcid":false,"given":"Malihe","family":"Mahmoudinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2024.102850_bib0001","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(07)60456-5","article-title":"Outcome of assisted reproduction","volume":"370","author":"Sutcliffe","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jogoh.2024.102850_bib0002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/tog.12504","article-title":"Complications of assisted reproductive technology treatment and the factors influencing reproductive outcome","volume":"20","author":"Bhandari","year":"2018","journal-title":"Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0003","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0025817216665074","article-title":"Fatal ovarian hyperstimulation syndrome in an anonymous egg donor","volume":"84","author":"Pooniya","year":"2016","journal-title":"Medico-Legal J"},{"issue":"10","key":"10.1016\/j.jogoh.2024.102850_bib0004","first-page":"711","article-title":"Conservative management of ovarian hyperstimulation syndrome","volume":"40","author":"Morris","year":"1995","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.jogoh.2024.102850_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00404-019-05163-3","article-title":"The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study","volume":"300","author":"Zeng","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.14684","article-title":"Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention","volume":"45","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0008","first-page":"31","article-title":"Outpatient management of severe ovarian hyperstimulation syndrome (OHSS) with placement of pigtail catheter","volume":"6","author":"Abuzeid","year":"2014","journal-title":"Facts Views Vis Obgyn"},{"issue":"5","key":"10.1016\/j.jogoh.2024.102850_bib0009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/molehr\/8.5.409","article-title":"The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome","volume":"8","author":"Albert","year":"2002","journal-title":"Mol Hum Reprod"},{"issue":"4\u20135","key":"10.1016\/j.jogoh.2024.102850_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1472-6483(10)60044-2","article-title":"Prevention of OHSS\u2013dopamine agonists","volume":"19","author":"Busso","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/16.1.24","article-title":"Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patients","volume":"16","author":"Al-Shawaf","year":"2001","journal-title":"Hum Reprod"},{"issue":"06","key":"10.1016\/j.jogoh.2024.102850_bib0014","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0030-1265679","article-title":"Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos","volume":"28","author":"D'Angelo","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0015-0282(03)00548-X","article-title":"Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome","volume":"80","author":"Chen","year":"2003","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.jogoh.2024.102850_bib0017","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"12","author":"Tso","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0018","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-1208.126293","article-title":"Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome","volume":"6","author":"Naredi","year":"2013","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"10.1016\/j.jogoh.2024.102850_bib0019","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10815-011-9708-4","article-title":"Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial","volume":"29","author":"Tehraninejad","year":"2012","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"10.1016\/j.jogoh.2024.102850_bib0020","first-page":"837","article-title":"Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study","volume":"11","author":"Torabizadeh","year":"2013","journal-title":"Iran J Reprod Med"},{"issue":"7","key":"10.1016\/j.jogoh.2024.102850_bib0021","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jogoh.2024.102850_bib0022","first-page":"248","article-title":"Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management","volume":"43","author":"Jahromi","year":"2018","journal-title":"Iran J Med Sci"},{"issue":"8","key":"10.1016\/j.jogoh.2024.102850_bib0023","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"\u00c1lvarez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.jogoh.2024.102850_bib0024","first-page":"48","article-title":"Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial","volume":"60","author":"Amir","year":"2015","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.jogoh.2024.102850_bib0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1472-6483(10)60401-4","article-title":"Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study","volume":"17","author":"Carizza","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogoh.2024.102850_bib0026","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S1472-6483(10)60452-X","article-title":"How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists","volume":"18","author":"Garcia-Velasco","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.jogoh.2024.102850_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008605.pub2","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","volume":"15","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0028","article-title":"Dopamine agonists for preventing ovarian hyperstimulation syndrome","volume":"4","author":"Tang","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2024.102850_bib0029","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00143.2009","article-title":"The role of calcium in the regulation of renin secretion","volume":"298","author":"Beierwaltes","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.jogoh.2024.102850_bib0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","article-title":"Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation-related pathways","volume":"82","author":"Tamarat","year":"2002","journal-title":"Lab Investig"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.fertnstert.2011.04.094","article-title":"Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome","volume":"96","author":"Gurgan","year":"2011","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jogoh.2024.102850_bib0032","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1016\/j.fertnstert.2009.07.1582","article-title":"Intravenous administration (IVI) of calcium (CA) effectively prevents the development of mild and severe forms of ovarian hyperstimulation syndrome (OHSS)","volume":"92","author":"Yakovenko","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jogoh.2024.102850_bib0033","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0034","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2014.09.046","article-title":"Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial","volume":"103","author":"El-Khayat","year":"2015","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jogoh.2024.102850_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.21608\/ebwhj.2018.7511","article-title":"Calcium infusion plus or minus cabergoline for prevention of ovarian hyperstimulation syndrome: Randomized double-blind placebo-controlled trial","volume":"8","author":"Sharafeldeen","year":"2018","journal-title":"Evidence Based Women's Health J"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0036","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.mefs.2018.05.001","article-title":"Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: a randomized clinical trial","volume":"23","author":"Elnory","year":"2018","journal-title":"Middle East Fertil Soc J"},{"issue":"6","key":"10.1016\/j.jogoh.2024.102850_bib0037","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0038","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01443615.2020.1870944","article-title":"Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study","volume":"42","author":"Fouda","year":"2022","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0039","first-page":"1248","article-title":"Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome","volume":"26","author":"Turktekin","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jogoh.2024.102850_bib0040","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.fertnstert.2009.05.021","article-title":"High dose cabergoline in management of ovarian hyperstimulation syndrome","volume":"92","author":"Ata","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jogoh.2024.102850_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.repbio.2019.03.005","article-title":"Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): a potentially safer and more effective protocol","volume":"19","author":"Gaafar","year":"2019","journal-title":"Reprod Biol"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0042","doi-asserted-by":"crossref","DOI":"10.1080\/23312025.2019.1668212","article-title":"The effects of oral calcium on the prevention of moderate to severe ovarian hyperstimulation syndrome in high-risk patients: a placebo-controlled study","volume":"5","author":"Rezaei","year":"2019","journal-title":"Cogent Biol"},{"issue":"1","key":"10.1016\/j.jogoh.2024.102850_bib0043","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09513590802404013","article-title":"Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial","volume":"25","author":"Galindo","year":"2009","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.jogoh.2024.102850_bib0044","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.jogoh.2024.102850_bib0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"10","key":"10.1016\/j.jogoh.2024.102850_bib0046","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"2014","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784724001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784724001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:57:53Z","timestamp":1737694673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784724001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2468784724001296"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2024.102850","relation":{},"ISSN":["2468-7847"],"issn-type":[{"type":"print","value":"2468-7847"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of intravenous calcium gluconate on the prevention of ovarian hyperstimulation syndrome. (A randomized clinical trial)","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2024.102850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102850"}}